Future liver remnant hypertrophy and postoperative outcomes: a retrospective comparison between segmental and main right portal vein embolization
Selective segmental right portal vein embolization, sparing the main right portal vein, offers a safe and effective alternative to MRPVE, achieving comparable FLR hypertrophy while potentially simplifying intraoperative procedures and reducing postprocedural complications. Future research should focus on conducting large, prospective, multicenter trials to further compare the long-term outcomes of this technique, particularly with regard to liver regeneration, postoperative liver function, complications and overall survival.
Authors
- Holger Gößmann
- Elif Can (ORCID: https://orcid.org/0000-0001-5319-7570)
- Felix Krenzien (ORCID: https://orcid.org/0000-0003-0593-9917)
- Wibke Uller (ORCID: https://orcid.org/0000-0001-6756-9005)
- Anne Pohrt (ORCID: https://orcid.org/0000-0001-6104-622X)
- Dominik Geisel (ORCID: https://orcid.org/0000-0001-7348-0971)
- Sophia Paparoditis
- Sebastian Ebel (ORCID: https://orcid.org/0000-0001-6856-6455)
- Bernhard Gebauer (ORCID: https://orcid.org/0000-0002-9948-7220)
- Uli Fehrenbach (ORCID: https://orcid.org/0000-0003-3622-3268)
- Michael Doppler
- Aboelyazid Elkilany (ORCID: https://orcid.org/0000-0002-4311-0520)
Institutions
- University of Freiburg (DE)
- Humboldt-Universität zu Berlin (DE)
- University Hospital Leipzig (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- CVIR Endovascular
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1186/s42155-025-00537-y
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00